169 related articles for article (PubMed ID: 35687559)
1. Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States.
Pawaskar M; Fergie J; Harley C; Samant S; Veeranki P; Diaz O; Conway JH
PLoS One; 2022; 17(6):e0269916. PubMed ID: 35687559
[TBL] [Abstract][Full Text] [Related]
2. Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland.
Heininger U; Pillsbury M; Samant S; Lienert F; Guggisberg P; Gani R; O'Brien E; Pawaskar M
Pediatr Infect Dis J; 2021 Jun; 40(6):e217-e221. PubMed ID: 33872276
[TBL] [Abstract][Full Text] [Related]
3. Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US.
Fergie J; Pawaskar M; Veeranki P; Samant S; Harley C; MacEwan J; Schwartz TT; Surati S; Conway JH
PLoS One; 2022; 17(6):e0269596. PubMed ID: 35749342
[TBL] [Abstract][Full Text] [Related]
4. Varicella vaccination in Italy : an economic evaluation of different scenarios.
Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial use for the management of varicella in Thailand: a retrospective observational study.
Chokephaibulkit K; Samant S; Chaisavaneeyakorn S; Kamolratanakul S; Limpadanai S; Kebede N; Stephens J; Sukarom I; Pawaskar M
Curr Med Res Opin; 2023 Jun; 39(6):873-880. PubMed ID: 37057414
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness and budget impact of universal varicella vaccination in Russia.
Marijam A; Safonova E; Scherbakov M; Shpeer E; Van Oorschot D; Rudakova A; Tatochenko V; Briko N
Hum Vaccin Immunother; 2022 Nov; 18(5):2045152. PubMed ID: 35258445
[TBL] [Abstract][Full Text] [Related]
7. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
[TBL] [Abstract][Full Text] [Related]
8. Acceptance of universal varicella vaccination among Swiss pediatricians and general practitioners who treat pediatric patients.
Lienert F; Weiss O; Schmitt K; Heininger U; Guggisberg P
BMC Infect Dis; 2021 Jan; 21(1):12. PubMed ID: 33407202
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of a routine varicella vaccination program for US children.
Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
[TBL] [Abstract][Full Text] [Related]
10. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
11. The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008-2019.
Pawaskar M; Gil-Rojas Y; Irene Parellada C; Rey-Velasco A; Beltrán C; Prieto E; Lasalvia P
Vaccine; 2022 Aug; 40(35):5095-5102. PubMed ID: 35871869
[TBL] [Abstract][Full Text] [Related]
12. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
[TBL] [Abstract][Full Text] [Related]
13. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
Goldman GS; King PG
Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
[TBL] [Abstract][Full Text] [Related]
14. Estimating the health economic impact of the universal varicella vaccination in Argentina from 2015 to 2019.
Giglio N; Lasalvia P; Pawaskar M; Parellada CI; Rosselli D; Babic VV; Neyro SE
Hum Vaccin Immunother; 2023 Aug; 19(2):2245703. PubMed ID: 37643745
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
Goldman GS
Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
[TBL] [Abstract][Full Text] [Related]
16. Early-Life Antibiotic Exposure Associated With Varicella Occurrence and Breakthrough Infections: Evidence From Nationwide Pre-Vaccination and Post-Vaccination Cohorts.
Lin TL; Fan YH; Chang YL; Ho HJ; Liang LL; Chen YJ; Wu CY
Front Immunol; 2022; 13():848835. PubMed ID: 35432330
[TBL] [Abstract][Full Text] [Related]
17. Health and Economic Impact of the United States Varicella Vaccination Program, 1996-2020.
Zhou F; Leung J; Marin M; Dooling KL; Anderson TC; Ortega-Sanchez IR
J Infect Dis; 2022 Oct; 226(Suppl 4):S463-S469. PubMed ID: 36265847
[TBL] [Abstract][Full Text] [Related]
18. Cost containment analysis of childhood vaccination against varicella in Israel.
Ginsberg GM; Somekh E
J Infect; 2004 Feb; 48(2):119-33. PubMed ID: 14720487
[TBL] [Abstract][Full Text] [Related]
19. Decline in annual incidence of varicella--selected states, 1990-2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(37):884-5. PubMed ID: 13679791
[TBL] [Abstract][Full Text] [Related]
20. Budget impact analysis of multiple varicella vaccination strategies: a Mexico perspective.
Graham J; Wolfson LJ; Kyle J; Bolde-Villarreal CP; Guarneros-DeRegil DB; Monsanto H; Pillsbury M; Talbird S; Daniels VJ
Hum Vaccin Immunother; 2020 Apr; 16(4):886-894. PubMed ID: 31567045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
